Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved the original application for dapagliflozin generic from Ajanta Pharma USA Inc., making the SGLT2 inhibitor available as a generic treatment for typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)